SOURCE: CDMRP, April 10, 2019
****
---------- Original message ---------
From: Communications@cdmrp.org <Communications@cdmrp.org>
Date: Wed, Apr 10, 2019 at 11:00 AM
Subject: JUST RELEASED! FY19 GWIRP, LRP, MRP and VRP Pre-Announcements
From: Communications@cdmrp.org <Communications@cdmrp.org>
Date: Wed, Apr 10, 2019 at 11:00 AM
Subject: JUST RELEASED! FY19 GWIRP, LRP, MRP and VRP Pre-Announcements
This e-mail is to notify the research community of recently released pre-announcements for the Gulf War Illness, Lupus, Melanoma, and Vision Research Programs managed by the Department of Defense office of Congressionally Directed Medical Research Programs (CDMRP) https://cdmrp.army.mil/pubs/ press/cdmrp_presses to allow investigators time to plan and develop ideas for submission to the anticipated FY19 funding opportunities.
FY19 funding opportunities are anticipated for the following programs:
Gulf War Illness Research Program (GWIRP)
* Idea Award
* Idea Development Award
* Clinical Evaluation Award
* Therapeutic/Biomarker Trial Award
* Patient-Provider and Health Communications Award
* New Investigator Award
Lupus Research Program (LRP)
* Concept Award
* Impact Award
Melanoma Research Program (MRP)
* Concept Award
* Idea Award
* Team Science Award
* Translational Research Award
Vision Research Program (VRP)
* Focused Translational Team Science Award
* Investigator-Initiated Research Award
* Translational Research Award
Descriptions of each of the anticipated funding opportunities, eligibility, key mechanism elements, and funding can be found in the Program pre-announcement. FY19 pre-announcements can be found in the CDMRP home page features at https://cdmrp.army.mil . Subsequent notifications will be sent when the program announcements/funding opportunities are released.
Please do not respond directly to this message. To be added or removed from this email list please use the “Subscribe/unsubscribe” to program specific news and updates at https://ebrap.org.
……………………………………………………………………………… …
CDMRP also provides news and updates through Facebook, Twitter and YouTube.
Follow CDMRP on Facebook: https://www.facebook.com/ TheCDMRP
Follow CDMRP on Twitter: https://twitter.com/CDMRP
Subscribe to CDMRP on YouTube: http://www.youtube.com/CDMRP
No comments:
Post a Comment
Your comments are welcome.
Please make it clear if you wish to receive a reply. All replies are posted as follow-on comments.
Please think before you post: **If you repeatedly post comments and then delete them, particularly after others reply to you, you will be justifiably banned**.